Zoek een klinische studie of trial
Andere zoekoptie(s)
9 Resultaat/Resultaten
Aanwerving proef
= 
; Lopend onderzoek
= 
; Terminated trial
= 
; Gefinancierd door een IRDiRC-lid = 
; Lid van een ERN = 
Nationale klinische studie(s)
FRANKRIJK
AUVERGNE-RHONE-ALPES
LYON
Randomised, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Tolerability of EPA-FFA Gastro-resistant Capsules, in Patients With Familial Adenomatous Polyposis (FAP) - FR
Hospices Civils de Lyon
FRANKRIJK
ILE-DE-FRANCE
BOBIGNY
Randomised, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Tolerability of EPA-FFA Gastro-resistant Capsules, in Patients With Familial Adenomatous Polyposis (FAP) - FR
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
FRANKRIJK
ILE-DE-FRANCE
PARIS
Randomised, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Tolerability of EPA-FFA Gastro-resistant Capsules, in Patients With Familial Adenomatous Polyposis (FAP) - FR
AP-HP.Sorbonne Université - Hôpital Saint-Antoine
CHU Paris Est - Hôpital Saint-Antoine
NEDERLAND
Noord-Holland
AMSTERDAM
The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Maag-Darm-Leveroncologie
SPANJE
Madrid
ADDRESS: NOT PROVIDED - ES
Randomised, double-blind, placebo-controlled study of the, efficacy, safety and tolerability of EPA-FFA gastro-resistant capsules, in patients with familial adenomatous polyposis (FAP) -ES
Institution: Information not provided - ES
USA
Washington
ADDRESS: NOT PROVIDED - US
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Institution: Information not provided - US
Multinationale klinische studie(s)
DUITSLAND
Berlin
ADDRESS: NOT PROVIDED - DE
Randomised, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Tolerability of EPA-FFA Gastro-resistant Capsules, in Patients With Familial Adenomatous Polyposis (FAP)
Institution: Information not provided - DE
USA
Washington
ADDRESS: NOT PROVIDED - US
Phase III Trial of the Safety and Efficacy of Eflornithine Combined With Sulindac Compared to Eflornithine, Sulindac as Single Agents in Patients With Familial Adenomatous Polyposis
Institution: Information not provided - US
VERENIGD KONINKRIJK
Greater London
ADDRESS: NOT PROVIDED - GB